DrMaryam Rahman
INTERIM CHAIR & PROF
MD-NEUROLOGICAL SURGERY
Orcid identifier0000-0003-3193-1273 (opens in a new tab)
- INTERIM CHAIR & PROFMD-NEUROLOGICAL SURGERY
GRANTS
- GRANTMicrogel delivery of total tumor antigen for the treatment of malignant gliomaOcala Royal Dames for Cancer Research24 Jun 2026 - 30 Jun 2028
- GRANTFlorida Center for Brain Tumor ResearchFlorida Department of Health5 May 2026 - 30 Jun 2027
- GRANTMicrogel-chemokine-matrix (MCM) for the treatment of malignant gliomaRising Tide Foundation for Clinical Cancer Research18 Mar 2026 - 18 Sep 2026
- GRANTThe Cathy D. Perry Trust, Advancing Precision Medicine: Integrating Laser Ablation and High throughput Screening for Personalized Therapeutics in Brain Tumor TreatmentOcala Royal Dames for Cancer Research2 Jun 2024 - 30 Jun 2026
- GRANTUnleashing the power of mRNA for treatment of malignant brain tumors using novel vaccine constructFlorida Department of Health1 Jan 2024 - 7 Dec 2025
- GRANTA phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 05/21/2020US Food and Drug Administration22 Aug 2022 - 31 Jul 2028
- GRANTRole of Natural Killer Cells in Efficacy of a Novel Glioblastoma mRNA VaccineAmerican Brain Tumor Association27 May 2022 - 31 Aug 2022
- GRANTAnalysis of gene expression profiling in banked blood samples to identify molecular and immune markers of effects of immune activation by LITT plus immune checkpoint inhibitors in glioblastoma by single cell analysisMonteris Medical12 Jul 2021 - 28 Feb 2026
- GRANTThe Immune Effects of a Novel Vaccine in Combination with Standard of CareAmerican Brain Tumor Association1 Jun 2021 - 31 Aug 2021
- GRANTOvercoming the blood-brain barrier with nanoparticle vaccines against gliomasNational Institute of Health Nci25 Jan 2021 - 31 Jan 2026
- GRANTHydrogel vaccine immunotherapy against brain tumorUF Foundation1 Jul 2020 - 31 Dec 2023
- GRANTIn situ modulation of DC vaccine to improve the immunotherapy efficacy against brain tumor by biocompatible Polyacrylamide-PEG hydrogelUF Foundation1 Jul 2020 - 30 Jun 2023
- GRANTA vaccine strategy to overcome treatment induced immunosuppression in gliomaAmerican Brain Tumor Association31 Dec 2019 - 1 Aug 2021
- GRANTRecurrent Brain Metastasis Immune Effects and RespOnse to Laser Interstitial ThermotHerapy (LITT) and Pembrolizumab in Combination (TORCH)Monteris Medical20 Sep 2019 - 28 Feb 2026
- GRANTFlorida Center for Brain Tumor ResearchFlorida Department of Health1 Jul 2018 - 30 Jun 2025
- GRANTLeveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in GlioblastomaNational Institute of Health Ninds15 Dec 2016 - 30 Nov 2022
- GRANTUSING SR233 FOR ENHANCING CELLULAR MIGRATION IN DENDRITICELL VACCINE THERAPY FOR MALIGNANT BRAIN TUMORSOcala Royal Dames for Cancer Research10 May 2016 - 30 Jun 2018